Clinical Trials Logo

Hemorrhage, Postpartum clinical trials

View clinical trials related to Hemorrhage, Postpartum.

Filter by:

NCT ID: NCT06452355 Not yet recruiting - Clinical trials for Postpartum Hemorrhage

Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage

SERENE
Start date: June 30, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of the KOKO™ device in the control and reduction of primary abnormal postpartum uterine bleeding or hemorrhage.

NCT ID: NCT05811676 Recruiting - Placenta Previa Clinical Trials

Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women With Placenta Previa

TRAPP
Start date: July 12, 2023
Phase: Phase 3
Study type: Interventional

Many RCT(randomized controlled trial) studies reported that tranexamic acid reduced blood loss in women who had elective cesareans. However, most of these elective cesareans are without high-risk factors of postpartum hemorrhage, such as placenta previa. The prophylactic use of tranexamic acid in the placenta previa is not clear. studies had poor quality and lacked adequate power to assess severe adverse events.

NCT ID: NCT05203016 Completed - Hypothermia Clinical Trials

Complications Associated With Intraoperative Hypothermia.

Start date: January 1, 2019
Phase:
Study type: Observational
Read more »
NCT ID: NCT04671680 Recruiting - Blood Pressure Clinical Trials

CNAP vs IABP in Pregnant Women With Placenta Accreta

Start date: January 15, 2021
Phase:
Study type: Observational

The objective of this study is to investigate a technique to monitor blood pressure in women undergoing cesarean delivery with suspected placenta accreta spectrum. To achieve this objective, the investigators plan to conduct a prospective, observational study with the following aims: Specific Aim 1: Compare concordance between the systolic (SBP), diastolic (DBP), and mean arterial blood pressure (MAP) readings from the continuous non-invasive arterial blood pressure (CNAP) and IABP at several discrete points throughout the procedure Specific Aim 2: Determine the feasibility of using CNAP to aid in decision making by examining the parameters of volume responsiveness and arterial elastance at several discrete points throughout the procedure. The investigators hypothesize that the investigators can obtain similar blood pressure monitoring using CNAP as compared to the gold standard IABP in women undergoing cesarean delivery with suspected placenta accreta.

NCT ID: NCT04370639 Completed - Hemorrhage Clinical Trials

A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage

Start date: May 20, 2020
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT04133402 Completed - Fertility Disorders Clinical Trials

Fertility After Intrauterine Tamponing Balloon: Where Are we

FERTIBTIU
Start date: November 19, 2019
Phase:
Study type: Observational

Today, few data are available on the patient's fertility following intrauterine tamponade balloon (BTIU) used for postpartum hemorrhage (PPH) after vaginal delivery (AVB). Several studies have concluded that there are no fertility disorders after conservative surgical treatment or embolization. BTIU is an essential treatment in the management of PPH. The aim was to evaluate post-BTIU fertility and the appearance of gynecological symptoms. This is a bicentric retrospective study (Valenciennes, Lille, France), between 2012 and 2017. The data will be collected by telephone interview on fertility and various gynecological functional symptoms.

NCT ID: NCT03912545 Completed - Trauma Clinical Trials

Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge

Start date: March 4, 2019
Phase:
Study type: Observational

This pilot study will evaluate the performance of the Quantra System comprised of the Quantra Hemostasis Analyzer with the QStat Cartridge in trauma patients or patients with OB hemorrhage.

NCT ID: NCT03723031 Recruiting - Clinical trials for Hemorrhage, Postpartum

Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section

Start date: November 15, 2018
Phase: Phase 2
Study type: Interventional

98 pregnant women attending for CS will be randomized into 2 groups. Rectal misopristol group who will receive 400 microgram misoprostol rectally preoperatively with urinary catheter insertion and intrauterine misopristol group will receive 400 microgram misoprostol intrauterine (200 microgram at each cornu) intraoperatively following the delivery of the placenta. The estimated blood loss for each patient will be measured and data of both groups will be compared.

NCT ID: NCT03233607 Completed - Clinical trials for Hemorrhage, Postpartum

Time of Postpartum Hemoglobin Assessment and Blood Loss During Delivery

QUOTABL
Start date: March 20, 2018
Phase:
Study type: Observational

This is a prospective cohort study of patients delivering at Columbia University Medical Center/ Allen Hospital. For the primary research question, the investigators will compare the change in maternal hemoglobin from postpartum day 1 to day 2 and also determine correlation with estimation of blood loss (EBL) and quantitative blood loss (QBL).

NCT ID: NCT03151070 Completed - Pre-Eclampsia Clinical Trials

Scaling Up an Integrated Approach to Improve Delivery Care in North Guatemala With Stepped Wedge Design

QVLM
Start date: December 15, 2013
Phase: N/A
Study type: Observational
Read more »